Ask the Experts: A Controversial Dialogue in Diabetes
Activity Overview
Please read the following information about this continuing education activity before accessing the presentation using the link located at the bottom of this page.
Release Date: April 1, 2014
Expiration Date: April 1, 2015
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-14-470-H01-P).
FOR NURSE PRACTITIONERS
This program is approved for 1.0 contact hour of continuing education (which includes 0.5 hour of pharmacology) by the American Association of Nurse Practitioners. Program ID 1402117. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.
FOR NURSES
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 5-115. This program is approved for 1 hour of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Methods and Format
This is an online activity consisting of audio and slides, an assessment (post-test), and a course evaluation. Participants should claim continuing education credit for this internet-based educational activity only if they have not claimed credit for the live activity. Participants must view the entire presentation, take the activity assessment, and complete the course evaluation to receive continuing education credit. A minimum score of 70% is required on the test for credit to be awarded, and participants may print their official statements of continuing education credit immediately. The estimated time to complete this activity is 1 hour. This activity is provided free of charge.
Target Audience
This continuing education activity was planned to meet the needs of pharmacists, nurses, nurse practitioners, and diabetes educators.
Activity Content
A variety of appropriate diabetic treatment regimens exist, and as a result, clinicians often face challenges in making treatment decisions for specific patients. During this activity, faculty will address some of these challenges from differing perspectives. Controversial topics will include sulfonylureas and cardiovascular disease, metformin in patients with renal dysfunction, clinical considerations with incretin agents, and avoiding noninsulin therapies in hospitalized diabetic patients.
Learning Objectives
At the conclusion of this application-based continuing education activity, participants should be able to
- Describe the benefits and risks of using traditional oral agents (e.g., sulfonylureas, metformin) in the management of type 2 diabetes.
- Given a patient scenario, devise an appropriate diabetes management plan that includes newer therapies.
- Summarize the rationale for avoiding the use of noninsulin therapies to manage hospitalized diabetic patients.
Faculty
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Assistant Director of Experiential Education
Associate Professor of Pharmacy Practice
Midwestern University
Chicago College of Pharmacy
Downers Grove, Illinois
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE, is Assistant Director of Experiential Education and Associate Professor, Department of Pharmacy Practice at Midwestern University Chicago College of Pharmacy, in Downers Grove, Illinois. Dr. Cornell is also a Certified Diabetes Educator and clinical pharmacy consultant, specializing in community and ambulatory care practice.
Dr. Cornell has over 24 years of practice in community pharmacy where she has practiced as a clinical pharmacist, diabetes educator, and preceptor, as well as the inaugural coordinator of the American Diabetes Association (ADA)-recognized Dominick’s Pharmacy Diabetes Self-Management Education program. Dr. Cornell’s current clinical practice is with the Access Community Health Network, where she trains, educates, and supervises students from the colleges of medicine, pharmacy, and health sciences as they provide diabetes education classes for patients in underserved community clinics.
Dr. Cornell received her Bachelor of Science degree in pharmacy from the University of Illinois, College of Pharmacy in 1986 and her Doctor of Pharmacy degree from Midwestern University in 2002.
Dr. Cornell recently completed her term as President of the Illinois Pharmacists Association in October 2011. She has received numerous awards and recognitions, including the 2010 Teacher of the Year Award, the 2010 American Association of Colleges of Pharmacy Student Engaged Community Service Award, and the 2005 Midwestern University Golden Apple Teaching Award. In 2008, she received fellow recognition from the American Association of Diabetes Educators (AADE) and the American Pharmacists Association. She is an active member of the ADA, as well as the AADE, where she served on the board of directors from 2004 to 2007.
Dr. Cornell has served as an invited speaker nationally and internationally on diabetes and its related conditions and is recognized as a key opinion leader in the field of diabetes education. She has contributed to many peer-reviewed print and online publications in this field.
Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE
Director, Education Services
Mid-America Diabetes Associates
Wichita, Kansas
Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE, is Director of Education Services at Mid-America Diabetes Associates. Ms. Hinnen provides clinical care and education to approximately 1,000 people with diabetes each year.
Ms. Hinnen has been a diabetes educator for over thirty years. She is involved extensively with the American Association of Diabetes Educators, having served as their national president. She was awarded their prestigious Distinguished Service Award and recently was honored with their fellow recognition. Ms. Hinnen has also served on the national board of directors for the American Diabetes Association and as an editor for Diabetes Spectrum. Her faculty positions are with the School of Pharmacy at the University of Kansas and with the Graduate Nursing Department and Physician Assistant Program at Wichita State University. Ms. Hinnen received fellow recognition from the American Academy of Nursing in 2003 and the American Association of Diabetes Educators in 2010.
Disclosure Statement
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Guidelines for Standards for Commercial Support, ASHP Advantage requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. A person has a relevant financial relationship if the individual or his or her spouse/partner has a financial relationship (e.g., employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring in the last 12 months with a commercial interest whose products or services may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on presentations.
All faculty and planners for ASHP Advantage education activities are qualified and selected by ASHP Advantage and required to disclose any relevant financial relationships with commercial interests. ASHP Advantage identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity.
The faculty listed below report the following relationships pertinent to this activity:
Susan Cornell, Pharm.D., CDE, FAPhA, FAADE
Dr. Cornell declares that she serves on the speakers bureau for the Johnson & Johnson Diabetes Institute and as an advisory panel member for Bristol-Myers Squibb and Astra Zeneca LP.
Debbie Hinnen, APRN, BC-ADM, CDE, FAAN, FAADE
Ms. Hinnen declares serves on the speakers bureau and as a consultant for Boehringer Ingelheim Pharmaceuticals, Bristol-Myers Squibb and Astra Zeneca LP, Eli Lilly, Pamlab, Roche, and Sanofi. She also serves as a consultant for Abbott and CeQur, and on the speakers bureau for Novo Nordisk.
Curtis L. Triplitt, Pharm.D., CDE
Dr. Triplitt declares that he serves on the speakers bureau for Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals and Eli Lilly, and Gilead.
The following planners report no relationships pertinent to this activity:
Kristi Hofer, Pharm.D.
Susan R. Dombrowski, M.S., B.S.Pharm.
ASHP staff has no relevant financial relationships to disclose.
Supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc., which was made possible, in part, through collaboration with Eli Lilly, and an independent medical education grant from Bristol-Myers Squibb and AstraZeneca LP.
Presentation
Launch Presentation (60 Minutes*)
*Allow additional time to complete the assessment and evaluation.
Download Assessment and Handout
Print the assessment (post-test) and handout of slides for your reference; however,your assessment must be submitted online.
Process CE
When you reach the end of the activity, follow instructions to complete the online process (i.e., take assessment test and complete evaluation) and obtain CE credit.
Additional Resources
For additional education and resources about this topic or to sign-up to be notified when new resources are available,visit www.leadingdiabetescare.org..
